Literature DB >> 3876831

Amino acid sequence of the trypsin-generated C3d fragment from human complement factor C3.

U Hellman, G Eggertsen, A Engström, J Sjöquist.   

Abstract

Human C3d (try-C3d), prepared from trypsin-digested C3, was fragmented by cleavage with CNBr. Eight peptides were defined and separated by h.p.l.c. on reversed-phase columns. By automatic Edman degradation the complete sequences of five peptides and partial sequences of three peptides were determined. To obtain overlapping peptides the latter three fragments were digested with trypsin, chymotrypsin or Staphylococcus aureus V8 proteinase, after which the fragments were separated on reversed-phase columns. Two of the CNBr-cleavage peptides were completely sequenced, and 70% of the sequence of the remaining CNBr-cleavage peptide was determined. The non-sequenced part represents a very hydrophobic segment of try-C3d. The sequence data obtained represent 90% of the primary structure of try-C3d. Alignment of the CNBr-cleavage fragments was made easier by comparison with the cDNA sequence of mouse pro-C3 [Wetsel, Lundwall, Davidson, Gibson, Tack & Fey (1984) J. Biol. Chem. 259, 13857-13862]. Comparison of try-C3d with the equivalent part of human C4B revealed an extensive sequence homology in the N-terminal half of the molecules.

Entities:  

Mesh:

Substances:

Year:  1985        PMID: 3876831      PMCID: PMC1152625          DOI: 10.1042/bj2300353

Source DB:  PubMed          Journal:  Biochem J        ISSN: 0264-6021            Impact factor:   3.857


  29 in total

Review 1.  Complement ligand-receptor interactions that mediate biological responses.

Authors:  D T Fearon; W W Wong
Journal:  Annu Rev Immunol       Date:  1983       Impact factor: 28.527

2.  Limited degradation of the third component (C3) of human complement by human leukocyte elastase (HLE): partial characterization of C3 fragments.

Authors:  J C Taylor; I P Crawford; T E Hugli
Journal:  Biochemistry       Date:  1977-07-26       Impact factor: 3.162

3.  Solid-phase edman degradation: attachment of carboxyl-terminal homoserine peptides to an insoluble resin.

Authors:  M J Horn; R A Laursen
Journal:  FEBS Lett       Date:  1973-11-01       Impact factor: 4.124

4.  An examination of conditions for the cleavage of polypeptide chains with cyanogen bromide: application to catalase.

Authors:  W A Schroeder; J B Shelton; J R Shelton
Journal:  Arch Biochem Biophys       Date:  1969-03       Impact factor: 4.013

5.  Chemical characterization of cyanogen bromide fragments from the beta-chain of human complement factor C3.

Authors:  A Lundwall; U Hellman; G Eggertsen; J Sjöquist
Journal:  FEBS Lett       Date:  1984-04-09       Impact factor: 4.124

6.  Structure of murine complement component C3. II. Nucleotide sequence of cloned complementary DNA coding for the alpha chain.

Authors:  R A Wetsel; A Lundwall; F Davidson; T Gibson; B F Tack; G H Fey
Journal:  J Biol Chem       Date:  1984-11-25       Impact factor: 5.157

7.  The molecular basis for the difference in immune hemolysis activity of the Chido and Rodgers isotypes of human complement component C4.

Authors:  D E Isenman; J R Young
Journal:  J Immunol       Date:  1984-06       Impact factor: 5.422

8.  An improved procedure for automated Edman degradation used for determination of the N-terminal amino acid sequence of human transcobalamin I and human intrinsic factor.

Authors:  J Thomsen; D Bucher; K Brunfeldt; H Olesen
Journal:  Eur J Biochem       Date:  1976-10-01

9.  Evidence for presence of an internal thiolester bond in third component of human complement.

Authors:  B F Tack; R A Harrison; J Janatova; M L Thomas; J W Prahl
Journal:  Proc Natl Acad Sci U S A       Date:  1980-10       Impact factor: 11.205

10.  A comparison of the properties of two classes, C4A and C4B, of the human complement component C4.

Authors:  S K Law; A W Dodds; R R Porter
Journal:  EMBO J       Date:  1984-08       Impact factor: 11.598

View more
  2 in total

1.  Proteinaceous inhibitors of phospholipase A2 purified from inflammatory sites in rats.

Authors:  Y Suwa; I Kudo; A Imaizumi; M Okada; T Kamimura; Y Suzuki; H W Chang; S Hara; K Inoue
Journal:  Proc Natl Acad Sci U S A       Date:  1990-04       Impact factor: 11.205

Review 2.  Auxiliary activation of the complement system and its importance for the pathophysiology of clinical conditions.

Authors:  Markus Huber-Lang; Kristina N Ekdahl; Rebecca Wiegner; Karin Fromell; Bo Nilsson
Journal:  Semin Immunopathol       Date:  2017-09-12       Impact factor: 9.623

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.